Click image to enlarge
The
V-PLEX platform offers analytically validated singleplex and multiplex assay kits. Developed under rigorous design control, V-PLEX kits provide accurate and reproducible results with consistency from lot to lot. The V-PLEX Plus Rat IL-6 Kit enables the measurement of IL-6 in a single-analyte format. For information on multiplexing IL-6 with other analytes, please see
V-PLEX Plus Proinflammatory Panel 2 Rat Kit.V-PLEX Plus kits include controls, wash buffer, and plate seals.
Related Key Terms:
BSF-2, CDF, IFN-β2, HSF, cytokine, interleukin, inflammation, acute phase response, immunity, automimmunity, cancer, multiple myeloma, allergy, asthma, multiple sclerosis, osteoporosis, cirrhosis, ischemia, berylliosis, arthritis, depression
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
|
Application(s)
|
|
Cytokines & Chemokines
,
Immunology/Inflammation
|
|
|
Analyte(s)
|
|
IL-6
|
|
|
Species
|
|
Rat
|
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
MESO SECTOR S 600MM
,
SECTOR Imager 6000
,
MESO QuickPlex SQ 120MM
,
MESO QuickPlex SQ 120
,
MESO SECTOR S 600
|
|
|
Plate Type
|
|
96-well
|
|
|
Capture Antibody
|
|
Mouse Monoclonal
|
|
|
Detection Antibody
|
|
Goat Polyclonal
|
|
|
LLOD (Sensitivity)
|
|
13.8 pg/mL
|
|
|
Dynamic Range
|
|
13.8 - 8,550 pg/mL
|
|
|
Sample Type
|
|
Serum, Plasma, Urine, Cell Culture Supernatant
|
|
|
Recombinant standards
|
|
Expressed in Insect cell line
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Statement(s)
|
|
Please refer to the product insert for the storage conditions of individual kit components.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Gene ID(s)
|
|
24498
|
|
|
UniProt ID(s)
|
|
P20607
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Proinflammatory Panel 1 Rat Control 1
|
2-8 °C
|
1 vial
(1 vial)
|
|
|
|
Proinflammatory Panel 1 Rat Control 2
|
2-8 °C
|
1 vial
(1 vial)
|
|
|
|
Proinflammatory Panel 1 Rat Control 3
|
2-8 °C
|
1 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
1 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
Proinflammatory Panel 2 (rat) Plate
|
2-8 °C
|
1 each
(1 each)
|
|
|
|
Diluent Assembly 7 (includes Diluent 40 – 5 mL, Diluent 42 – 10 mL)
|
≤-10 °C
|
1 each
|
|
|
|
|
RT
|
1 bottle
(100 mL)
|
|
|
|
|
RT
|
1 bottle
(50 mL)
|
|
|
|
Blocker H, 20 mL
|
RT
|
1 bottle
(20 mL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Proinflammatory Panel 1 Rat Control 1
|
2-8 °C
|
5 vial
(1 vial)
|
|
|
|
Proinflammatory Panel 1 Rat Control 2
|
2-8 °C
|
5 vial
(1 vial)
|
|
|
|
Proinflammatory Panel 1 Rat Control 3
|
2-8 °C
|
5 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
5 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
Proinflammatory Panel 2 (rat) Plate
|
2-8 °C
|
5 each
(1 each)
|
|
|
|
Diluent Assembly 8 (includes Diluent 40 – 25 mL, Diluent 42 – 50 mL)
|
≤-10 °C
|
1 each
|
|
|
|
|
RT
|
1 bottle
(100 mL)
|
|
|
|
|
RT
|
1 bottle
(50 mL)
|
|
|
|
Blocker H, 100 mL
|
RT
|
1 bottle
(100 mL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Proinflammatory Panel 1 Rat Control 1
|
2-8 °C
|
25 vial
(1 vial)
|
|
|
|
Proinflammatory Panel 1 Rat Control 2
|
2-8 °C
|
25 vial
(1 vial)
|
|
|
|
Proinflammatory Panel 1 Rat Control 3
|
2-8 °C
|
25 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
25 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
Proinflammatory Panel 2 (rat) Plate
|
2-8 °C
|
25 each
(1 each)
|
|
|
|
Diluent Assembly 8 (includes Diluent 40 – 25 mL, Diluent 42 – 50 mL)
|
≤-10 °C
|
5 each
|
|
|
|
|
RT
|
5 bottle
(100 mL)
|
|
|
|
|
RT
|
5 bottle
(50 mL)
|
|
|
|
Blocker H, 100 mL
|
RT
|
5 bottle
(100 mL)
|
|
|
|
Product Inserts
|
|
|
|
Certificate of analysis
|
|
View More
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
Twenty-eight day repeated exposure of human 3D bronchial epithelial model to heated tobacco aerosols indicates decreased toxicological responses compared to cigarette smoke
|
|
|
|
Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms
|
|
|
|
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations
|
|
|
|
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
|
|
|
|
IL-6 as a Mediator of the Association Between Traditional Risk Factors and Future Myocardial Infarction: A Nested Case-Control Study
|
|
|
|
|
View All
|
Related Products
|
Product Name
|
Applications |
Species |
Plate Type |
|
V-PLEX Rat IL-6 Kit
|
|
|
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters